Appropriateness of dabigatran dosing in patients with non-valvular atrial fibrillation (NVAF): A retrospective study conducted in a tertiary care university hospital in the Eastern Province of Saudi Arabia

ConclusionThis study revealed inappropriate prescription of reduced doses of dabigatran in a large number of patients. Age was identified as the main driving factor for underdosing. Physicians’ and pharmacists’ awareness regarding this type of high-risk medication should be improved to ensure appropriate and safe use of this commonly used drug.
Source: Journal of the Saudi Heart Association - Category: Cardiology Source Type: research